Notice of Results | 08-Feb-2023 | 07:00 | RNS |
Holding(s) in Company | 07-Dec-2022 | 14:37 | RNS |
Final Pricing Determination | 30-Nov-2022 | 07:00 | RNS |
Total Voting Rights | 30-Nov-2022 | 07:00 | RNS |
Block Listing Six Monthly Return | 15-Nov-2022 | 07:00 | RNS |
Director share purchases | 03-Nov-2022 | 07:00 | RNS |
Half-year Report | 26-Sep-2022 | 07:00 | RNS |
Notice of Results | 09-Sep-2022 | 07:00 | RNS |
New York State approval for commercial testing | 02-Sep-2022 | 07:00 | RNS |
Block Listing Six Monthly Return | 16-May-2022 | 07:00 | RNS |
Result of AGM | 11-May-2022 | 15:17 | RNS |
Publication of AR and Accounts & Notice of AGM | 08-Apr-2022 | 07:00 | RNS |
Preliminary Results | 28-Mar-2022 | 07:00 | RNS |
VA sites in validation study; SAB appointment | 17-Mar-2022 | 07:00 | RNS |
First patient enrolment for LungLB® study | 02-Feb-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 18.20p |
Change Today | -0.30p |
% Change | -1.62 % |
52 Week High | 123.00 |
52 Week Low | 18.20 |
Volume | 2,509 |
Shares Issued | 25.49m |
Market Cap | £4.64m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:05 | 2,509 @ 18.75p |
You are here: research